Liver cancer stage 3 Doctors Abroad — Page 3

Associate Professor Dr. Yusuf Acikgoz brings expertise from Ohio State University – now leading oncology cases at Lokman Hekim University Ankara Hospital.

• Specialized in Medical Oncology with 10 years of experience of focused training
• Participated in international Phase III clinical trials for advanced cancer treatments
• Fluent in English with multiple international certifications
• Member of the American Society of Clinical Oncology

Dr. Fox specializes in innovative treatments for liver cancer, combining chemotherapy, immunotherapy, and targeted therapies.

• Chief Physician at BKZ Solingen, a certified cancer center
• Expert in molecular diagnostics and personalized treatment plans
• Active member of the American Association for Cancer Research
• Involved in research on molecular biology of haemato-oncological diseases

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• 2016 years of experience of experience in oncology
• Specializes in complex cancer cases
• Worked at Ankara Oncology Clinic and other leading hospitals
• Promoted to Associate Professor in 2016

Professor Keil specializes in advanced diagnostic and interventional radiology, including liver cancer imaging and treatment at the Academic Hospital Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in modern imaging techniques like CT and MRI for interventions
• Served as Chief Physician of Radiology at Academic Hospital Solingen
• Trained under renowned Professor Rolf W. Günther in Aachen

Specializing in virotherapy – a cutting-edge immunotherapy approach for liver cancer – Dr. Jaunalksne brings 49 years of experience of immunology expertise.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunotherapies for cancer treatment

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Dr. Alemdar specializes in liver cancer treatment with a strong academic background and extensive hospital experience.

• Over 20 years of experience of experience in internal medicine and oncology
• Trained in medical oncology at Akdeniz University Faculty of Medicine
• Has worked at multiple leading hospitals in Turkey
• Member of the Turkish Medical Oncology Association

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Specialized in advanced laparoscopic and oncological cancer surgery at prestigious Istanbul University hospitals. Performs minimally invasive techniques for complex liver cancer cases.

• Board-certified with over 16 years of experience of surgical experience
• Received specialized training in laparoscopic antireflux and bariatric surgery
• Advanced fellowship in oncological cancer surgery techniques
• Performs surgery at Büyük Anadolu Hospitals

Specializes in liver cancer treatment with extensive experience in medical oncology. Dr. Ozden focuses on personalized care for stage 3 liver cancer patients at VM Medical Park Pendik Hospital.

• 27 years of experience of medical oncology subspecialty training at Kocaeli University Faculty of Medicine
• 27 years of experience of experience in internal medicine and oncology
• Trained at Istanbul University's Cerrahpaşa Faculty of Medicine – one of Turkey's top medical schools

Associate Professor Nail Paksoy specializes in liver cancer at Medipol Bahçelievler Hospital, with extensive research in oncology.

• ESMO Board Certified in Medical Oncology
• Active participant in international clinical trials for cancer treatments
• Published multiple research papers on various cancer types
• Fellowship trained at Istanbul University Oncology Institute

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Auala Hubert heads the Gastrointestinal Cancer Center at Hadassah Medical Center, with 36 years of experience in oncology and radiotherapy.

• Specializes in medical oncology and radiotherapy for liver cancer
• Senior physician at Hadassah University Hospital's Oncology Department
• Trained at Hebrew University and Hadassah University Hospital
• Member of Israel Society of Clinical Oncology and Cancer Association

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Associate Professor Babek Tabandeh specializes in liver cancer surgery and minimally invasive techniques at Medical Park Goztepe Hospital.

• of experience in general surgery
• Author of over 40 medical documents
• Member of the American College of Surgeons and Liver Transplantation Society
• Teaches at Bahçeşehir University Faculty of Medicine

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.